Machine learning study: from the toxicity studies to tetrahydrocannabinol effects on Parkinson's disease

ArticleAçık Erişim

Özet

Aim: Investigating molecules having toxicity and chemical similarity to find hit molecules. Methods: The machine learning (ML) model was developed to predict the arylhydrocarbon receptor activity of anti-Parkinson's and US FDA-approved drugs. The ML algorithm was a support vector machine, and the dataset was Tox21. Results: The ML model predicted apomorphine in anti-Parkinson's drugs and 73 molecules in FDA-approved drugs as active. The authors were curious if there is any molecule like apomorphine in these 73 molecules. A fingerprint similarity analysis of these molecules was conducted and found tetrahydrocannabinol (THC). Molecular docking studies of THC for dopamine receptor 1 (affinity = -8.2 kcal/mol) were performed. Conclusion: THC may affect dopamine receptors directly and could be useful for Parkinson's disease. © 2023 Newlands Press.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12217Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4155/fmc-2022-0181Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorYucel, Mehmet Ali
dc.contributor.authorOzcelik, Ibrahim
dc.contributor.authorAlgul, Oztekin
dc.date.accessioned2026-10-18T20:27:08.690478847Z
dc.date.available2026-10-18T20:27:08.690478847Z
dc.date.issued2023
dc.description.abstractAim: Investigating molecules having toxicity and chemical similarity to find hit molecules. Methods: The machine learning (ML) model was developed to predict the arylhydrocarbon receptor activity of anti-Parkinson's and US FDA-approved drugs. The ML algorithm was a support vector machine, and the dataset was Tox21. Results: The ML model predicted apomorphine in anti-Parkinson's drugs and 73 molecules in FDA-approved drugs as active. The authors were curious if there is any molecule like apomorphine in these 73 molecules. A fingerprint similarity analysis of these molecules was conducted and found tetrahydrocannabinol (THC). Molecular docking studies of THC for dopamine receptor 1 (affinity = -8.2 kcal/mol) were performed. Conclusion: THC may affect dopamine receptors directly and could be useful for Parkinson's disease. © 2023 Newlands Press.
dc.description.sponsorshipThis study was carried out within the scope of the 2022 Graduation Research Project of the Faculty of Pharmacy of the Erzincan Binali Yıldırım University. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
dc.identifier.doi10.4155/fmc-2022-0181
dc.identifier.eissn1756-8927
dc.identifier.endpage377
dc.identifier.issn1756-8919
dc.identifier.issue4
dc.identifier.pmid36942739
dc.identifier.scopus2-s2.0-85151044030
dc.identifier.startpage365
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12217
dc.identifier.volume15
dc.identifier.wosWOS:000953997000001
dc.language.isoen
dc.publisherNewlands Press Ltd
dc.relation.ispartofFuture Medicinal Chemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAHR
dc.subjectdopamine receptor
dc.subjectmachine learning
dc.subjectParkinson's disease
dc.subjecttetrahydrocannabinol
dc.subjectApomorphine
dc.subjectDopamine Agonists
dc.subjectDronabinol
dc.subjectHumans
dc.subjectMolecular Docking Simulation
dc.subjectParkinson Disease
dc.subjectabacavir
dc.subjectantiparkinson agent
dc.subjectarylhydrocarbon receptor
dc.subjectbenflumetol
dc.subjectcarbidopa
dc.subjectcrystal violet
dc.subjectdiosmetin
dc.subjectdopamine
dc.subjectdopamine 1 receptor
dc.subjectdopamine receptor stimulating agent
dc.subjectendocannabinoid
dc.subjectfebuxostat
dc.subjectgalantamine
dc.subjectimatinib
dc.subjectimiquimod
dc.subjectlansoprazole
dc.subjectleflunomide
dc.subjectligand
dc.subjectminocycline
dc.titleMachine learning study: from the toxicity studies to tetrahydrocannabinol effects on Parkinson's disease
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus2
rdl.citation.wos1
rdl.departmentDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Erzincan Binali Yildirim University, Erzincan, 24100, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)